BPC-157 vs Pinealon
Extensively Studied vs Well Studied
compatible Different mechanisms with no known interactions.
Molecular Data
BPC-157 Pinealon
Weight 1,419.53 Da 418.4 Da
Half-life <30 minutes Not established
Chain 15 amino acids 3 amino acids
Type Pentadecapeptide Tripeptide
Key Benefits
BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
Pinealon
01 Direct DNA interaction
02 Neuroprotection
03 Cognitive enhancement
04 Excellent safety profile
05 40+ years of clinical use in Russia
Dosing Protocols
BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
Pinealon
Injectable: 5mg daily or 100-300mcg daily; Oral: 0.2mg twice daily / Injectable: daily for 20 days; Oral: morning and afternoon on empty stomach
Neuroprotection 5mg daily Once daily
Cognitive Enhancement 100-300mcg Daily or every other day
Anti-aging 5mg 20 days, 2-3x yearly
Side Effects
BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
Pinealon
Minimal injection site reactions
Mild gastrointestinal adjustment
Occasional headache
Fatigue
Contraindications
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Pregnancy
Lactation
Research Evidence
BPC-157 Pinealon
Status Extensively Studied Well Studied
References 6 studies 4 studies
Latest January 2025 —
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.